About this trial
This project aims to implement and evaluate a dyadic intervention (i.e., acceptance commitment therapy) for persons with AD/ADRD and their care partners. We hypothesize the intervention will be feasible, acceptable, and show preliminary efficacy of the dyadic interveniotns.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
18+
MMSE= 21-27
Able to communicate in English
18+
Disqualifiers
Currently in an intervention for reducing anxiety or depression related to their dementia
MMSE= 28+ or less than 21
MMSE= <28
Is a formal (paid) caregiver
Trial design
Single group
Treatments tested in this trial
Acceptance Commitment Therapy
BehavioralAcceptance and Commitment Therapy (ACT) is a form of cognitive-behavioral therapy that aims to enhance psychological flexibility through six core processes: acceptance, cognitive defusion, being present, self-as-context, values clarification, and committed action. Rather than attempting to eliminate difficult thoughts and feelings, ACT encourages individuals to accept them while committing to behavior changes consistent with their personal values.
Treatment groups
Trial outcomes
Primary outcomes
Patient Health Questionnaire-9
PHQ-9 is used to assess the presence and severity of depressive symptoms.
Geriatric Depression Short From
GDS short is a brief, self-report screening tool designed to identify depressive symptoms in older adults.
The Generalized Anxiety Disorder-7
GAD-7 is used to assess the severity of generalized anxiety symptoms
General Anxiety Scale-10
The GAS-10 is designed to assess the severity of general anxiety symptoms
Secondary outcomes
Dyadic Coping Inventory
The DCI assess how couples support each other and cope together with stress.
Short Form Health Survey (SF-12)
The SF-12 measures functional health and well-being
Purpose in Life Scale
The PIL is designed to assess an individual's sense of meaning and purpose in life.
Herth Hope Index
The HHI is designed to measure an individual's level of hope
Sponsors and contacts
Click on the lead sponsor to view all of their trials.